Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: A cohort study

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Hallström, Helena ^a,c   Melhus, Håkan ^b,c   Glynn, Anders ^a   Lind, Lars ^c   Syvänen, Ann Christine ^c   Michalsson, Karl ^b,c  

^a NATIONAL FOOD ADMINISTRATION   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYTOCHROME P450 1A2;

AGED; ARTICLE; BONE DENSITY; CALCIUM INTAKE; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FEMUR NECK; FOOD INTAKE; GENOTYPE; HUMAN; MALE; NUTRITIONAL ASSESSMENT; OSTEOLYSIS;

EID: 77649292823     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-12     Document Type: Article

References (75)

1. Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. RP Heaney RR Recker, J Lab Clin Med 1982 99 46 55 7054349
2. The effect of dietary caffeine on urinary excretion of calcium, magnesium, sodium and potassium in healthy young females. LK Massey KJ Wise, Nutrition Research 1984 4 43 50 10.1016/S0271-5317(84)80132-3
3. Calcium metabolism in postmenopausal osteoporotic women is determined by dietary calcium and coffee intake. C Hasling K Sondergaard P Charles L Mosekilde, J Nutr 1992 122 1119 1126 1564564
4. Caffeine, urinary calcium, calcium metabolism and bone. LK Massey SJ Whiting, J Nutr 1993 123 1611 1614 8360789
5. An investigation of sources of variation in calcium absorption efficiency. MJ Barger-Lux RP Heaney SJ Lanspa JC Healy HF DeLuca, J Clin Endocrinol Metab 1995 80 406 411 10.1210/jc.80.2.406 7852497
6. Effects of caffeine on bone and the calcium economy. RP Heaney, Food Chem Toxicol 2002 40 1263 1270 10.1016/S0278-6915(02)00094-7 12204390
7. How do reproductive and lifestyle factors influence bone density in distal and ultradistal radius of early postmenopausal women? The Nord-Trondelag Health Survey, Norway. S Forsmo B Schei A Langhammer L Forsen, Osteoporos Int 2001 12 222 229 10.1007/s001980170133 11315241
8. A longitudinal study of bone density in midlife women. K Holm A Dan J Wilbur S Li J Walker, Health Care Women Int 2002 23 678 691 10.1080/ 07399330290107421 12418988
9. To drink or not to drink: how are alcohol, caffeine and past smoking related to bone mineral density in elderly women? JZ Ilich RA Brownbill L Tamborini Z Crncevic-Orlic, J Am Coll Nutr 2002 21 536 544 12480799
10. Effects of caffeine, vitamin D, and other nutrients on quantitative phalangeal bone ultrasound in postmenopausal women. H Rico ML Canal P Manas JM Lavado C Costa JD Pedrera, Nutrition 2002 18 189 193 10.1016/S0899-9007(01) 00718-3 11844651
11. Lifestyle factors are associated with osteoporosis in lean women but not in normal and overweight women: a population-based cohort study of 1222 women. R Korpelainen J Korpelainen J Heikkinen K Vaananen S Keinanen-Kiukaanniemi, Osteoporos Int 2003 14 34 43 10.1007/s00198-002-1319-6 12577183
12. Bone mass in physicians: a Howard University Hospital pilot study. MO Reyes JA Archer G Nunlee-Bland G Daniel OA Morgan K Makambi, J Natl Med Assoc 2004 96 299 305 15040511
13. Osteoporosis risk factors in rural and urban women from the Lublin Region of Poland. RS Filip J Zagorski, Ann Agric Environ Med 2005 12 21 26 16028861
14. Effects of coffee consumption and smoking habit on bone mineral density. D Demirbag F Ozdemir M Ture, Rheumatol Int 2006 26 530 535 10.1007/s00296-005- 0020-4 16025331
15. Does bone mineral density and knowledge influence health-related behaviors of elderly men at risk for osteoporosis? A Patel PS Coates JB Nelson DL Trump NM Resnick SL Greenspan, J Clin Densitom 2003 6 323 330 10.1385/JCD:6:4:323 14716044
16. Coffee drinking: a minor risk factor for bone loss and fractures. C Johansson D Mellstrom U Lerner T Osterberg, Age Ageing 1992 21 20 26 10.1093/ageing/21.1.20 1553855
17. Determinants of bone mineral density in older men. NW Glynn EN Meilahn M Charron SJ Anderson LH Kuller JA Cauley, J Bone Miner Res 1995 10 1769 1777 10.1002/jbmr.5650101121 8592955
18. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. MT Hannan DT Felson B Dawson-Hughes KL Tucker LA Cupples PW Wilson DP Kiel, J Bone Miner Res 2000 15 710 720 10.1359/jbmr.2000. 15.4.710 10780863
19. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. JA Cauley RL Fullman KL Stone JM Zmuda DC Bauer E Barrett-Connor K Ensrud EM Lau ES Orwoll, Osteoporos Int 2005 16 1525 1537 10.1007/s00198-005-1866-8 15889316
20. Determinants of bone mass and bone size in a large cohort of physically active young adult men. JA Ruffing F Cosman M Zion S Tendy P Garrett R Lindsay JW Nieves, Nutr Metab (Lond) 2006 3 14 10.1186/1743-7075-3-14 16480509
21. Factors affecting bone mineral density in men. E Atalar G Aydin I Keles E Inal G Zog A Arslan S Orkun, Rheumatol Int 2009 29 1025 1030 10.1007/s00296-008-0768-4 19082599
22. Caffeine and bone loss in healthy postmenopausal women. SS Harris B Dawson-Hughes, Am J Clin Nutr 1994 60 573 578 8092093
23. Intake of caffeine and other methylxanthines during pregnancy and risk for adverse effects in pregnant women and their foetuses. HC Andersson H Hallström BA Kihlman, Edited by the Nordic Council of Ministers, Copenhagen. Tema Nord 2004 565
24. Functional significance of a C -A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. C Sachse J Brockmoller S Bauer I Roots, Br J Clin Pharmacol 1999 47 445 449 10.1046/j.1365-2125.1999.00898.x 10233211
25. Human cytochrome P4501A2. MT Landi R Sinha NP Lang FF Kadlubar, Metabolic Polymorphisms and Susceptibility to Cancer. Publ. No. 148 International Agency for Research on Cancer Lyon. IARC Sci, Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P, 1999 173 195
26. Coffee, CYP1A2 genotype, and risk of myocardial infarction. MC Cornelis A El-Sohemy EK Kabagambe H Campos, Jama 2006 295 1135 1141 10.1001/jama.295.10. 1135 16522833
27. Gender differences in pharmacological response. GD Anderson, Int Rev Neurobiol 2008 83 1 10 10.1016/S0074-7742(08)00001-9 18929073
28. Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS). http://www.medsci.uu.se/pivus/pivus.htm
29. Systolic and diastolic hypertension impair endothelial vasodilatory function in different types of vessels in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. L Lind, J Hypertens 2006 24 1319 1327 10.1097/01.hjh.0000234112.38863.6f 16794481
30. Befolkningens kostvanor och näringsintag i Sverige 1989. Metod och resultatanalys. (Dietary habits and nutrient intake in Sweden 1989. Methods and analysis.). W Becker, Report in Swedish with English summary Nutritional Unit, Swedish National Food Administration 1994
31. Precoded or weighed food records for measuring dietary habits in a population of Swedish adults. I. Food intake. W Becker MM Lennernäs IB Gustafsson, The Sixth Nordic Conference in Nutrition: Göteborg, Sweden 1996
32. Epidemiology and outcomes of osteoporotic fractures. SR Cummings LJ Melton, Lancet 2002 359 1761 1767 10.1016/S0140-6736(02)08657-9 12049882
33. CYP1A2 phenotype and genotype in a population from the Carboniferous Region of Coahuila, Mexico. F Castorena-Torres A Mendoza-Cantu MB de Leon B Cisneros O Zapata-Perez L Lopez-Carrillo JE Salinas A Albores, Toxicol Lett 2005 156 331 339 10.1016/j.toxlet.2004.12.005 15763632
34. Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2. XM Han DS Ou-Yang PX Lu CH Jiang Y Shu XP Chen ZR Tan HH Zhou, Pharmacogenetics 2001 11 429 435 10.1097/00008571-200107000-00006 11470995
35. The International HapMap Project. http://www.hapmap.org/
36. The SNP Technology Platform at Uppsala University. http://www.genotyping. se
37. Highly parallel SNP genotyping. JB Fan A Oliphant R Shen BG Kermani F Garcia KL Gunderson M Hansen F Steemers SL Butler P Deloukas L Galver S Hunt C McBride M Bibikova T Rubano J Chen E Wickham D Doucet W Chang D Campbell B Zhang S Kruglyak D Bentley J Haas P Rigault L Zhou J Stuelpnagel MS Chee, Cold Spring Harb Symp Quant Biol 2003 68 69 78 10.1101/sqb.2003.68.69 15338605
38. Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. H Petersson L Lind J Hulthe A Elmgren T Cederholm U Riserus, Atherosclerosis 2009 203 298 303 10.1016/j.atherosclerosis.2008.06.020 18687433
39. Uppsala Longitudinal Study of Adult Men (ULSAM). http://www.pubcare.uu. se/ULSAM/
40. Leisure physical activity and the risk of fracture in men. K Michaelsson H Olofsson K Jensevik S Larsson H Mallmin L Berglund B Vessby H Melhus, PLoS Med 2007 4 199 10.1371/journal.pmed.0040199 17579509
41. Predictive value of BMD for hip and other fractures. O Johnell JA Kanis A Oden H Johansson C De Laet P Delmas JA Eisman S Fujiwara H Kroger D Mellstrom PJ Meunier LJ Melton T O'Neill H Pols J Reeve A Silman A Tenenhouse, J Bone Miner Res 2005 20 1185 1194 10.1359/JBMR.050304 15940371
42. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. O Johnell JA Kanis, Osteoporos Int 2006 17 1726 1733 10.1007/s00198-006-0172-4 16983459
43. The socioeconomic burden of fractures: today and in the 21st century. O Johnell, Am J Med 1997 103 20S 25S discussion 25S-26S 10.1016/S0002-9343(97) 90023-1 9302894
44. Is caffeine consumption a risk factor for osteoporosis? C Cooper EJ Atkinson HW Wahner WM O'Fallon BL Riggs HL Judd LJ Melton, J Bone Miner Res 1992 7 465 471 10.1002/jbmr.5650070415 1609631
45. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. DC Bauer WS Browner JA Cauley ES Orwoll JC Scott DM Black JL Tao SR Cummings, Ann Intern Med 1993 118 657 665 8460853
46. Caffeine and other predictors of bone density among pre- and perimenopausal women. M Hernandez-Avila MJ Stampfer VA Ravnikar WC Willett I Schiff M Francis C Longcope SM McKinlay C Longscope, Epidemiology 1993 4 128 134 8452901
47. Coffee-associated osteoporosis offset by daily milk consumption. The Rancho Bernardo Study. E Barrett-Connor JC Chang SL Edelstein, Jama 1994 271 280 283 10.1001/jama.271.4.280 8295286
48. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. LA Rubin GA Hawker VD Peltekova LJ Fielding R Ridout DE Cole, J Bone Miner Res 1999 14 633 643 10.1359/jbmr.1999.14.4.633 10234586
49. Potential risk factors for development of postmenopausal osteoporosis - examined over a 12-year period. MA Hansen K Overgaard BJ Riis C Christiansen, Osteoporos Int 1991 1 95 102 10.1007/BF01880450 1790399
50. Risk factors for decreased bone density in premenopausal women. C Krahe R Friedman JL Gross, Braz J Med Biol Res 1997 30 1061 1066 10.1590/S0100- 879X1997000900003 9458965
51. Correlates of cortical bone mass among premenopausal and postmenopausal Japanese women. JM Lacey JJ Anderson T Fujita Y Yoshimoto M Fukase S Tsuchie GG Koch, J Bone Miner Res 1991 6 651 659 10.1002/jbmr.5650060702 1950670
52. Dietary caffeine intake and bone status of postmenopausal women. T Lloyd N Rollings DF Eggli K Kieselhorst VM Chinchilli, Am J Clin Nutr 1997 65 1826 1830 9174479
53. Dietary caffeine intake is not correlated with adolescent bone gain. T Lloyd NJ Rollings K Kieselhorst DF Eggli E Mauger, J Am Coll Nutr 1998 17 454 457 9791842
54. Bone status among postmenopausal women with different habitual caffeine intakes: a longitudinal investigation. T Lloyd N Johnson-Rollings DF Eggli K Kieselhorst EA Mauger DC Cusatis, J Am Coll Nutr 2000 19 256 261 10763907
55. Caffeine does not affect the rate of gain in spine bone in young women. PT Packard RR Recker, Osteoporos Int 1996 6 149 152 10.1007/BF01623939 8704354
56. Premenopausal bone mineral content relates to height, weight and calcium intake during early adulthood. D Picard LG Ste-Marie D Coutu L Carrier R Chartrand R Lepage P Fugere P D'Amour, Bone Miner 1988 4 299 309 3191285
57. Determinants of the rate of bone loss in normal postmenopausal women. IR Reid RW Ames MC Evans SJ Sharpe GD Gamble, J Clin Endocrinol Metab 1994 79 950 954 10.1210/jc.79.4.950 7962303
58. Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women. MA Hansen, Osteoporos Int 1994 4 123 128 10.1007/BF01623056 8069050
59. Cigarette smoking, alcohol and caffeine consumption, and bone mineral density in postmenopausal women. The Nottingham EPIC Study Group. MJ Grainge CA Coupland SJ Cliffe CE Chilvers DJ Hosking, Osteoporos Int 1998 8 355 363 10.1007/s001980050075 10024906
60. Direct effects of caffeine on osteoblastic cells metabolism: the possible causal effect of caffeine on the formation of osteoporosis. YH Tsuang JS Sun LT Chen SC Sun SC Chen, J Orthop Surg Res 2006 1 7 10.1186/1749-799X-1-7 17150127
61. Caffeine Induces Cell Death via Activation of Apoptotic Signal and Inactivation of Survival Signal in Human Osteoblasts. PZ Lu CY Lai WH Chan, Int J Mol Sci 2008 9 698 718 10.3390/ijms9050698 19325779
62. Reciprocal roles between caffeine and estrogen on bone via differently regulating cAMP/PKA pathway: the possible mechanism for caffeine-induced osteoporosis in women and estrogen's antagonistic effects. Y Zhou ZL Zhu XX Guan WW Hou HY Yu, Med Hypotheses 2009 73 83 85 10.1016/j.mehy.2009.01.029 19278793
63. Teratogenicity of paraxanthine (1,7-dimethylxanthine) in C57BL/6J mice. RG York JL Randall WJ Scott Jr, Teratology 1986 34 279 282 10.1002/tera. 1420340307 3798364
64. Metabolism of caffeine and other components of coffee. MJ Arnaud, Caffeine, Coffee and Health New York: Raven Press, Garattini S, 1993 43 95
65. Sympathomimetic effects of paraxanthine and caffeine in humans. NL Benowitz P Jacob H Mayan C Denaro, Clin Pharmacol Ther 1995 58 684 691 10.1016/0009-9236(95)90025-X 8529334
66. Pharmacology of caffeine. Institute of Medicine (U.S.). Committee on Military Nutrition Research, Caffeine for the sustainment of mental task performance: formulations for military operations Washington, D.C.: National Academy Press 2001 25 32
67. Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells. OA Gressner B Lahme M Siluschek AM Gressner, Liver Int 2009 29 886 897 10.1111/j.1478-3231.2009.01987.x 19291178
68. Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor beta. O Fromigue D Modrowski PJ Marie, Current pharmaceutical design 2004 10 2593 2603 10.2174/1381612043383773 15320747
69. Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin. BA Evans C Elford A Pexa K Francis AC Hughes A Deussen J Ham, J Bone Miner Res 2006 21 228 236 10.1359/JBMR.051021 16418778
70. Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk. K Michaelsson H Melhus R Bellocco A Wolk, Bone 2003 32 694 703 10.1016/S8756-3282(03)00048-6 12810177
71. First- and second-year effects in trials of calcium supplementation on the loss of bone density in postmenopausal women. D Mackerras T Lumley, Bone 1997 21 527 533 10.1016/S8756-3282(97)00181-6 9430243
72. Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. AE Smedman IB Gustafsson LG Berglund BO Vessby, Am J Clin Nutr 1999 69 22 29 9925119
73. Self-report reliability and symptomatology of habitual caffeine consumption. JE James MS Bruce MH Lader NR Scott, Br J Clin Pharmacol 1989 27 507 514 2719904
74. Swedish Mammography Cohort. http://www.imm.ki.se/smc/history/index.html
75. Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. SC Larsson L Bergkvist A Wolk, Cancer Causes Control 2009 20 2039 2044 10.1007/s10552-009-9396-x